跳至主要内容
临床试验/NCT00906347
NCT00906347已完成4 期

A Randomized, Controlled Trial of Oral Misoprostol for Labor Augmentation

University of Texas Southwestern Medical Center1 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2008年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
350
试验地点
1
主要终点
Uterine Tachysystole

研究概览

简要总结

This is a prospective, randomized, controlled trial designed to examine the efficacy of oral misoprostol for labor augmentation compared to a standard regimen of intravenous oxytocin.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Clinical decision to augment labor
  • Gestational age > than or equal to 36 weeks
  • Singleton gestation
  • Cephalic presentation
  • Reassuring fetal heart rate tracing
  • Cervical dilation between 4 and 8 cm
  • Ruptured membranes with clear amniotic fluid
  • Intrauterine pressure catheter in place
  • Less than 200 MVUs in a 10 minute period
  • 5 or fewer contractions in a 10 minute period
  • English or Spanish speaking patient

排除标准

  • Non-reassuring fetal heart rate tracing at time of enrollment
  • Meconium stained amniotic fluid
  • Previous uterine incision
  • Maternal fever (defined as greater than 37.9 C)
  • Known fetal anomalies
  • Placenta previa or unexplained vaginal bleeding
  • Estimated fetal weight of 4,500 grams or more
  • Abnormal maternal bony pelvis
  • Grandmultiparity

研究组 & 干预措施

Oxytocin augmentation

Active Comparator

Women with hypotonic labor and a clinical decision to proceed with labor augmentation will receive intravenous oxytocin.

干预措施: Oxytocin (Drug)

Misoprostol augmentation

Active Comparator

Women with hypotonic labor and a clinical decision to proceed with labor augmentation will receive oral misoprostol.

干预措施: Misoprostol (Drug)

结局指标

主要结局

Uterine Tachysystole

时间窗: Up to four hours after administration of study drug

Defined as six contractions in two consecutive 10-minute periods

次要结局

  • Infant Apgar Score <4(5 minutes after delivery)
  • Umbilical Cord Artery pH <7.1(Obtained at delivery)
  • Admission of Neonatal Intensive Care Unit(Until hospital discharge)
  • Maternal Chorioamnionitis(During labor)
  • Maternal Hypovolemia Requiring Blood Transfusion(Until hospital discharge)
  • Method of Delivery(At delivery)
  • Time Elapsed From Start of Labor Augmentation to Delivery(Initiation of augmentation until delivery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Trial of Oral Misoprostol for Labor Augmentation | 临床试验